Gerber Foundation

The Gerber Foundation operates as a focused, mission-driven private foundation with a 70-year legacy rooted in Gerber Products Company's original philanthropic commitment to infant and child welfare. Founded in 1952 by Daniel Gerber Sr. as the Gerber Baby Foods Fund (starting with just $14,700 in grants), the Foundation became independently endowed in 1994 and has since grown its asset base to $102.7 million. This institutional history matters for applicants: the Foundation has deep, principled roots in evidence-based child health, and proposals that feel generic or disconnected from that legacy fare poorly.

The Foundation channels its giving through three distinct programs, each with its own eligibility universe. The Research Grants program — representing over 70% of total grantmaking — exclusively funds 501(c)(3) organizations and public institutions with U.S.-based principal investigators. The West Michigan Grants program is geographically restricted to nonprofits serving Lake, Muskegon, Newaygo, and Oceana Counties in Michigan, with grants oriented toward youth programming for ages 0-18. Scholarships round out the portfolio but are not applicable to most organizational grant seekers.

For research applicants, the relationship progression is structured and uncompromising. Stage one is a brief concept paper written in lay terms — reviewers include both board laypeople and medical professionals — submitted online. The Foundation advances approximately 10% of concept paper submissions to full proposal stage, making this the hardest filter in the process. Full proposals then pass through a subcommittee with external expert reviewers before reaching the full board, with 35-50% of full proposals ultimately funded. The entire cycle spans roughly 10 months from concept paper to funding notification.

First-time applicants should understand that the Foundation is not a passive funder: it actively values investigator accessibility and dialogue. Staff explicitly encourage researchers to reach out during the application process for guidance. This is not performative — the Foundation's small staff structure (Executive Director Sara Hohnstein, MSW; Program Administrator Sally Hall, MA) means that early contact can help align your submission to board preferences before submission. Board members include multiple MDs (William Bush, Randall Dyk, Raymond Hutchinson, Robert Schumacher) whose clinical perspectives shape which concept papers advance.

The Gerber Foundation has sustained remarkably consistent annual grantmaking over the past decade, averaging approximately $4.5 million in total giving per year. Specific figures by year: $4,147,087 (2015), $4,385,616 (2019), $3,294,242 (2020), $5,179,917 (2021), $5,409,258 (2022), and $4,374,548 (2023). The 2020 dip to $3.3 million likely reflects COVID-era operational disruptions. Total assets grew from $62.7 million in 2012 to $102.7 million in 2024 — a 64% increase — while net investment income has generally ranged from $3.0-3.4 million annually (with an exceptional $17.5 million in 2021, presumably a market-driven spike). The 2023 payout rate was approximately 4.5% of assets, consistent with private foundation minimum distribution requirements.

Grant sizing breaks sharply across programs. Research Major Awards cap at $350,000 total (inclusive of 10% indirect cost maximum) over up to three years. Recent funded projects cluster between $250,000-$350,000: Mark Geil PhD ($314,513 for infant crawling development), Seth Goldstein MD ($330,019 for neonatal ischemia), Jonathan Levin MD ($349,885 for preterm infant feeding), and Angelica Meinhofer PhD ($250,000 for neonatal opioid withdrawal syndrome). Novice Research Awards cap at $30,000, a distinct entry-level track for early-career researchers within or within one year of post-training. West Michigan community grants average under $5,000 and almost never exceed $10,000.

Geographically, research grants reach nationally and occasionally internationally (case-by-case basis for non-U.S. projects), while West Michigan grants are strictly confined to four counties. The Foundation awards approximately 10-15 research grants per annual cycle. With $4.4 million in giving in 2023 and community grants averaging under $5,000, the overwhelming majority of funding flows through research awards. Organizations in the research space should budget proposals in the $200,000-$350,000 range for maximum competitiveness at the major award level.

The Foundation's peers by asset size (all near the $102-103 million band) are primarily private independent foundations in the Philanthropy & Grantmaking category. However, the Gerber Foundation is distinguished from its size peers by its unusually tight programmatic focus and active research grant infrastructure.

The Gerber Foundation stands apart from its asset-size peers in several meaningful ways. First, it operates a structured, competitive grant program with published deadlines, eligibility criteria, and online submission infrastructure — relatively rare among foundations of this size. Second, its 70-year institutional mission creates predictable, durable funding priorities that larger or newer foundations often lack. Third, the Foundation's all-volunteer board (zero officer compensation) and lean staff model means overhead is exceptionally low, directing a higher share of investment income toward grantmaking. For applicants, this concentrated focus is both a constraint (no mission creep, no exceptions) and an asset: if your work fits within the pre-birth to age-3 window on health, nutrition, or environmental hazards, you are engaging a funder that is genuinely expert in your domain.

The Foundation's most visible recent activity centers on the 2026 research grant cycle, announced in October 2025 with concept papers due February 2, 2026 and full proposals due July 15, 2026. Duke University's Pediatric Research office published the cycle announcement on October 23, 2025, reflecting the Foundation's reach into major academic medical centers nationwide.

On the community side, 2025-2026 West Michigan grant recipients highlight the Foundation's dual identity as both a national research funder and a hyperlocal community investor. Recent awards include youth robotics (NC PEERS Inc., NC GEARS/COGS program), performing arts education (West Michigan Symphony, Link Up Music for 3rd graders), summer camp access (TrueNorth Community Services), children's clothing (Operation Warm Inc., Muskegon and Oceana PreK), and local police-community engagement (City of Fremont Police, Shop with a Cop Christmas Event).

The Foundation's homepage highlighted three recent impact stories in early 2026: a local 4-H program investment in West Michigan, active fetal surgery research focused on vein of Galen malformation treatment in neonates, and ongoing human milk research. The vein of Galen study signals continued engagement with high-acuity neonatal interventions, consistent with board members who hold active pediatric clinical practices.

No major leadership transitions or endowment restructurings have been publicly announced. The board has remained stable with President Fernando Flores-New (Houston, TX) and a consistent cohort of physician-directors. Sara Hohnstein, MSW continues as Executive Director. Assets grew from $96.4M (2023) to $102.7M (2024), a 6.5% increase driven by $10.9M in total revenue.

Tailor the concept paper to lay readers first, scientists second. The Foundation explicitly states concept papers must be written in lay terms because the reviewing subcommittee includes non-specialist board members alongside medical professionals. A concept paper that leads with clinical jargon will stall at this first filter. Open with the problem in plain terms: how many infants are affected, what happens if the problem goes unsolved, and what your study uniquely contributes.

Lead with translational impact, not mechanisms. The board is looking for 'new information, treatments or tools that will result in a change in practice.' Proposals that emphasize basic science pathways without a clear clinical application timeline are historically less competitive. Your concept paper should answer: what will a pediatrician, NICU nurse, or parent be able to do differently in 3-5 years because of your study?

Align your focus area explicitly to the three program pillars. State clearly whether your proposal addresses Pediatric Health (disease reduction, developmental outcomes), Pediatric Nutrition (nutrient science, feeding issues), or Environmental Hazards (NICU exposures, home environment, breastmilk contaminants). Proposals that straddle multiple areas without a primary anchor can lose focus during review.

Use the cover letter strategically. The required cover letter from a senior officer or department chair should do more than introduce the PI — it should make the institutional case for fit. Reference the Foundation's mission language directly. A department chair who can speak to the PI's track record with applied pediatric research adds credibility that the proposal itself cannot.

Watch your budget ceilings carefully. Indirect costs cannot exceed 10% of the total award (not the direct cost base). PI/Co-PI combined effort cannot exceed 30% of salary. NIH salary cap applies to base salary. For novice awards ($30,000 cap), applicant salary may not exceed 50% of the budget and conference travel is limited to $2,000. Submit a budget that fits cleanly within these constraints on first submission — revisions signal inexperience.

Contact staff before submitting. The Foundation unusually and explicitly encourages applicants to reach out during the application process. Use this. A brief email to tgf@gerberfoundation.org asking whether your concept aligns with current board priorities can prevent a wasted submission cycle and signals genuine engagement with the funder.